Eli Lilly has announced its new digital healthcare experience, LillyDirect, which will benefit patients in the US with obesity, migraine and diabetes. This is intended to offer resources around disease management, such as access to healthcare providers, tailored support and delivery of selected medications.
The programme will provide patients with LillyDirect Pharmacy Solutions, a digital pharmacy for select Lilly medications utilising third-party online pharmacy fulfillment services; disease and healthcare educational information; access to telehealth providers; and an independent search tool allowing patients to access healthcare professionals near then.
Frank Cunningham, group vice president, global value and access at Lilly, stated: "We know that people have come to depend on the efficiency and convenience of digital solutions to meet a variety of their everyday needs – healthcare being one of them. We launched LillyDirect with the hope that it will offer patients an innovative end-to-end experience to manage their health and access their medicines, so they can get back to living their lives."
David A Ricks, Lilly’s chair and chief executive officer, commented: "A complex US healthcare system adds to the burdens patients face when managing a chronic disease. With LillyDirect, our goal is to relieve some of those burdens by simplifying the patient experience to help improve outcomes. LillyDirect offers more choices in how and where people access healthcare, including a convenient home delivery option to fill Lilly medicines they have been prescribed."
According to the company’s press release, ‘LillyDirect will continue to be updated and expanded to improve the customer experience. Future updates may include new products, partners and services, such as programs designed to help patients with adherence to their medicines’.
Pharmaceutical Industry news, analysis and insights